Skip to content

Is dry needling an effective physiotherapy management strategy for adults with cervicogenic or tension-type headache?

Does giving adults (aged 18-65) with a clinical diagnosis of cervicogenic or tension-type headache a dry needling and standard physiotherapy intervention have an effect on their headache pain severity? (No comparator - single group study).

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613001333707
Enrollment
30
Registered
2013-12-05
Start date
2013-12-15
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study's purpose is to generate preliminary data on the efficacy of the addition of dry needling to standard physiotherapy management in the treatment of headaches, as well as to determine the feasibility of running an efficacy trial for this condition. This will involve the collection of a small set of data on the efficacy of dry needling for headaches, and to determine the feasibility of running a trial collecting this data. This will allow determination of a sample size estimate, the availability of eligible participants, the willingness for subjects to be recruited, and adherence rates to management, enabling evaluation of the feasibility of a future successful, cost-effective large-scale efficacy trial. We hypothesise that: 1. An efficacy trial is a feasible means to study the impact of dry needling on cervicogenic and tension-type headache 2. Standard physiotherapy plus dry needling changes the severity, frequency and disability of cervicogenic and tension-type headache pain in adults

Interventions

The addition of dry needling to standard physiotherapy treatment (such as massage, stretches, manipulation/mobilisation and exercises). Dry needling will be applied by a qualified physiotherapist. Single-use sterile needles (50mm long with 0.25-0.30mm gauge) will be inserted superficially only (5-10mm) into myofascial trigger points around the head, neck and back. Needles will remain in position for 10-15 minutes and needles may be manipulated within this time. Approximately 8-15 needles will b

The addition of dry needling to standard physiotherapy treatment (such as massage, stretches, manipulation/mobilisation and exercises). Dry needling will be applied by a qualified physiotherapist. Single-use sterile needles (50mm long with 0.25-0.30mm gauge) will be inserted superficially only (5-10mm) into myofascial trigger points around the head, neck and back. Needles will remain in position for 10-15 minutes and needles may be manipulated within this time. Approximately 8-15 needles will be inserted at each appointment. The standard physiotherapy treatment type, dosage and duration will be applied as indicated at the discretion of the treating student physiotherapist, within evidence based guidelines. The total appointment time for each participant will be approximately half an hour. Participants will attend appointments 1-2 times per week at first, and appointments will become less frequent at the treating physiotherapist's discretion, until they decide treatment is no longer needed. Each participant will receive a minimum of 2 weeks treatment and a maximum of 8 weeks treatment.

Sponsors

The University of South Australia
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Clinical diagnosis of cervicogenic or tension-type headache using the International Classification of Headache Disorders-II Adult males and females Sufficient English to understand the purpose of the trial, give informed consent and complete outcome measures

Exclusion criteria

Prophylaxis treatment in the last 6 months Standard dry needling exclusions including: History of haemorrhagic disease, blood-borne disease, diabetes mellitus, unstable epilepsy, peripheral neuropathy Immunologically compromised (acute immune disorders, cancer) Incompetent heart valve or valve replacements, recent cardiac surgery, acute cardiac arrhythmias, congestive cardiac failure Infections, oedema Pregnancy Metal allergies Medications that may be affected by autonomic reaction (blood pressure, diabetes medications) Anticoagulant medication

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026